- Home
- TASK vs SRPT Comparison
TASK vs SRPT Comparison
Compare TASK & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TASK
- SRPT
- Stock Information
- Founded
- TASK 2008
- SRPT 1980
- Country
- TASK United States
- SRPT United States
- Employees
- TASK N/A
- SRPT N/A
- Industry
- TASK Retail: Computer Software & Peripheral Equipment
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- TASK Technology
- SRPT Health Care
- Exchange
- TASK Nasdaq
- SRPT Nasdaq
- Market Cap
- TASK 1.5B
- SRPT 1.7B
- IPO Year
- TASK 2021
- SRPT 1997
- Fundamental
- Price
- TASK $17.04
- SRPT $15.91
- Analyst Decision
- TASK Buy
- SRPT Hold
- Analyst Count
- TASK 6
- SRPT 29
- Target Price
- TASK $17.67
- SRPT $46.46
- AVG Volume (30 Days)
- TASK 182.1K
- SRPT 20.7M
- Earning Date
- TASK 08-11-2025
- SRPT 08-06-2025
- Dividend Yield
- TASK N/A
- SRPT N/A
- EPS Growth
- TASK 15.14
- SRPT N/A
- EPS
- TASK 0.60
- SRPT N/A
- Revenue
- TASK $1,045,307,000.00
- SRPT $2,233,371,000.00
- Revenue This Year
- TASK $14.37
- SRPT $3.52
- Revenue Next Year
- TASK $8.00
- SRPT N/A
- P/E Ratio
- TASK $28.33
- SRPT N/A
- Revenue Growth
- TASK 14.05
- SRPT 59.15
- 52 Week Low
- TASK $10.57
- SRPT $10.42
- 52 Week High
- TASK $19.60
- SRPT $145.00
- Technical
- Relative Strength Index (RSI)
- TASK 57.77
- SRPT 42.26
- Support Level
- TASK $17.00
- SRPT $10.42
- Resistance Level
- TASK $17.13
- SRPT $19.24
- Average True Range (ATR)
- TASK 0.10
- SRPT 2.12
- MACD
- TASK -0.03
- SRPT 0.80
- Stochastic Oscillator
- TASK 26.54
- SRPT 44.13
About TASK TaskUs Inc.
TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to the world's most innovative companies, helping its clients represent, protect and grow their brands. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.